Литература
1. Machado F.R., Azevedo L.C.P. Sepsis: a threat that needs a global solution // Crit. Care Med. 2018. Vol. 46, N 3. P. 454-459.
2. Александрович Ю.С., Иванов Д.О., Пшениснов К.В. Сепсис новорожденных. СПб., 2018. 174 с.
3. Singer M., Deutschman C.S., Seymour C.W. et al. The Third International Definitions of Sepsis and Septic Shock (Sepsis-3) // JAMA. 2016. Vol. 315, N 8. P. 801-810.
4. Wynn J.L. Defining neonatal sepsis // Curr. Opin. Pediatr. 2016. Vol. 28, N 2. P. 135-140.
5. Weston E.J., Pondo T., Lewis M.M. et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008 // Pediatr. Infect. Dis. J. 2011. Vol. 30. P. 937-941.
6. Vergnano S., Menson E., Kinnea N. et al. Neonatal infections in England: the NeonIN surveillance network // Arch. Dis. Child. Fetal Neonatal Ed. 2011. Vol. 96. P. F9-F14.
7. Stoll B.J., Hansen N.I., Sanchez PJ. et al. Early-onset neonatal sepsis the burden of group B Streptococcal and E. coli disease continues // Pediatrics. 2011. Vol. 127. P. 817-826.
8. Thaver D., Zaidi A.K. Burden of neonatal infections in developing countries: a review of evidence from community-based studies // Pediatr. Infect. Dis. J. 2009. Vol. 28, N 1. Suppl. P. S3-S9.
9. Weiss S.L., Fitzgerald J.C., Balamuth F. et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis // Crit. Care Med. 2014. Vol. 42. P. 2409-2417.
10. National Institute for Health and Clinical Excellence (NICE). Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection (Clinical Guideline CG149). August 2012. (дата обращения: 23 января 2017 г.)
URL: https://www.nice.org.uk/guidance/cg149
11. Wynn J.L., Wong H.R. Pathophysiology and treatment of septic shock in neonates // Clin. Perinatol. 2010. Vol. 37, N 2. P. 439-479.
12. Hornik C.P., Benjamin D.K., Becker K.C. et al. Use of the complete blood cell count in early- onset neonatal sepsis // Pediatr. Infect. Dis. J. 2012. Vol. 31. P. 799-802.
13. Connell T.G., Rele M., Cowley D. et al. How reliable as a negative blood culture result? Volume of blood submitted for culture in routine practice in a children’s hospital // Pediatrics. 2007. Vol. 119,N 5. P. 891896.
14. Stoll B.J., Hansen N.I., Adams-Chapman I. et al.; National Institute in Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infections // JAMA. 2004. Vol. 292, N 19. P. 2357-2365.
15. De Prost N., Razazi K., Brun-Buisson C. Unrevealing culture-negative severe sepsis // Crit. Care. 2013. Vol. 348. P. 1546-1554.
16. Fjalstad J.W., Stensvold H.J., Bergseng H. et al. Early-onset sepsis and antibiotic exposure in term infants: a nationwide population-based study in Norway // Pediatr. Infect. Dis. J. 2016. Vol. 35. P. 1-6.
17. Schulfer A., Blaser M.J. Risks of antibiotic exposures in life of the developing microbiome // PLoS Pathog. 2015. Vol. 11. Article ID e1004903.
18. Centres for Disease Control and Prevention (CDC). CDC 12-step program to prevent antimicrobial resistance in health care settings. April 19, 2002. (дата обращения: 23 января 2017 г.)
URL: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5115a5.htm
19. World Health Organization (WHO). World Health Organization Global Strategy for Containment of Antimicrobial Resistance. 2001. (дата обращения: 23 января 2017 г.)
URL: https://www.who.int/drugresistance/WHO_Global_Strategy.htm/en/
20. Cantey J.B., Patel S.J. Antimicrobial stewardship in the NICU // Infect. Dis. Clin. North Am. 2014. Vol. 28. P. 247-261.
21. Patel S.J., Rosen E., Zaoutis T. et al. Neonatologists’ perceptions of antimicrobial resistance and stewardship in neonatal intensive care unit // Infect. Control Hosp. Epidemiol. 2010. Vol. 31. P. 1298-1300.
22. Holmes A.H. Understanding the mechanisms and drivers of antimicrobial resistance // Lancet. 2016. Vol. 387. P. 176-187.
23. De Santis V., Gresiou M., Corona A. et al. Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013 // J. Antimicrob. Chemother. 2015. Vol. 70. P. 273278.
24. Ruppe E., Woerther P.L., Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli // Ann. Intensive Care. 2015. Vol. 5. P. 61.
25. Rhodes A., Evans L.E., Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 // Intensive Care Med. 2017. Vol. 43. P. 304-377.
26. De Jong E., Van Oers J.A., Beishuizen A. et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomized, controlled, open-label trial // Lancet Infect. Dis. 2016. Vol. 16. P. 819-827.
27. Baer G., Baumann P., Buettcher M. et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial // PLoS One. 2013. Vol. 8. Article ID e68419.
28. Deftos L.J., Roos B.A., Parthemore J.G. Calcium and skeletal metabolism // West. J. Med. 1975. Vol. 123, N 6. P. 447-458.
29. Гельфанд Б.Р., Бурневич С.З., Гельфанд Е.Б., Бражник Т.Б. и др. Биохимические маркеры системной воспалительной реакции: роль прокальцитонина в диагностике сепсиса // Инфекции в хирургии. 2007. Т. 5, № 1. С. 17-24.
30. Вельков В.В. Прокальцитонин и С-реактивный белок в современной лабораторной диагностике // Клинико-лабораторный консилиум. 2009. № 1 (26). С. 34-48.
31. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection and sepsis: clinical utility and limitation // Crit. Care Med. 2008. Vol. 36, N 3. P. 941-995.
32. Vouloumanou E.K., Plessa E. et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and metaanalysis // Intensive Care Med. 2011. Vol. 37. P. 747 - 762.
33. Van Rossum A.M., Wulkan R.W. et al. Procalcitonin as an early marker of infection in neonates and children // Lancet Infect. Dis. 2004. Vol. 4. P. 620-630.
34. Chiesa C., Panero A., Rossi N. et al. Reliability of procalcitonin concentration for the diagnosis of sepsis in critically ill neonates // Clin. Infect. Dis. 1998. Vol. 26. P. 664-672.
35. Trippella G., Galli L., De Martino M., Lisi C. et al. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and metaanalysis // Expert Rev. Anti Infect Ther. 2017. Vol. 15, N 11. P. 1041-1057.
36. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials // Crit. Care Med. 2010. Vol. 38, N 11. P. 2229-2241.
37. Assumma M., Signore F., Rossi N. et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study // Clin. Chem. 2003. Vol. 49. P. 60-68.
38. Chiesa C., Pelegrini G., Panero A. et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications and infection // Clin. Chem. 2003. Vol. 49. P. 60-68.
39. Lee J., Bang Y.H., Lee E.H. et al. The influencing factors on procalcitonin values in newborns with noninfectious conditions during the fist week of life // Korean J. Pediatr. 2017. Vol. 60, N 1. P. 10-16.
40. Kordek A., Torbe A., Tousty J. et al. The determination of procalcitonin concentration in early-onset neonatal infection // Clin. Pediatr. (Phila.). 2017. Vol. 56, N 4. P. 333-340.
41. Stocker M., Fontana M., El Helou S. et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial // Neonatology. 2010. Vol. 97. P. 165-174.
42. Stocker M., Herk W., El Helou S. et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomized controlled trial (NeoPIns) // Lancet. 2017. Vol. 390. P. 871-881.
43. Vinclair C., Timsit J.F., Bouadma L. The NeoPIns study: a step towards a rational use of antibiotics in early-onset sepsis in term neonates // J. Emerg. Crit. Care Med. 2017. Vol. 1. P. 45.
44. Merker M., Bolliger R., Schuetz P. Procalcitonin-guided decision making results in a significant reduction of antibiotic therapy and hospital stay in neonates with suspected early-onset sepsis // BMJ Evidence-Based Medici ne On line. First pu blished on March 9, 2018.
URL: https://pubmed.ncbi.nlm.nih.gov/30054447-procalcitonin-guided-decision-making-results-in-a-significant-reduction-of-antibiotic-therapy-and-hospital-stay-in-neonates-with-suspected-early-onset-sepsis/
doi: 10.1136/bmjebm-2017-110838
45. Aravena M. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis // Rev. Chilena Infectol. 2017. Vol. 34, N 5. P. 522.
46. Mathur N.B., Behera B. Blood procalcitonin levels and duration of antibiotics in neonatal sepsis // J. Trop. Pediatr. 2018. Aug 24. P. 1-6.
References
1. Machado F.R., Azevedo L.C.P Sepsis: a threat that needs a global solution. Crit Care Med. 2018; 46 (3): 454-9.
2. Aleksandrovich Yu.S., Ivanov D.O., Pshenisnov K.V. Sepsis of newborn. Saint Petersburg, 2018: 174. (in Russian)
3. Singer M., Deutschman C.S., Seymour C.W., et al. The Third International Definitions of Sepsis and Septic Shock (Sepsis-3). JAMA. 2016; 315 (8): 801-10.
4. Wynn J.L. Defining neonatal sepsis. Curr Opin Pediatr. 2016; 28 (2): 135-40.
5. Weston E.J., Pondo T., Lewis M.M., et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J. 2011; 30: 937-41.
6. Vergnano S., Menson E., Kinnea N., et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011; 96: F9-14.
7. Stoll B.J., Hansen N.I., Sanchez P.J.. et al. Early-onset neonatal sepsis the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011; 127: 817-26.
8. Thaver D., Zaidi A.K. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009; 28 (1): S3-9.
9. Weiss S.L., Fitzgerald J.C., Balamuth F., et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med. 2014; 42: 2409-17.
10. National Institute for Health and Clinical Excellence (NICE). Antibiotics for early-onset neonatal infection: antibiotics for the prevention and treatment of early-onset neonatal infection (Clinical Guideline CG149). August 2012. URL: https://www.nice.org.uk/guidance/cg149 . (date of access January 23, 2017)
11. Wynn J.L., Wong H.R. Pathophysiology and treatment of septic shock in neonates. Clin Perinatol. 2010; 37 (2): 439-79.
12. Hornik C.P., Benjamin D.K., Becker K.C., et al. Use of the complete blood cell count in early- onset neonatal sepsis. Pediatr Infect Dis J. 2012; 31: 799-802.
13. Connell T.G., Rele M., Cowley D., et al. How reliable as a negative blood culture result? Volume of blood submitted for culture in routine practice in a children’s hospital. Pediatrics. 2007; 119 (5): 891-6.
14. Stoll B.J., Hansen N.I., Adams-Chapman I., et al.; National Institute in Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infections. JAMA. 2004; 292 (19): 2357-65.
15. De Prost N., Razazi K., Brun-Buisson C. Unrevealing culture-negative severe sepsis. Crit Care. 2013; 348: 1546-54.
16. Fjalstad J.W., Stensvold H.J., Bergseng H., et al. Early-onset sepsis and antibiotic exposure in term infants: a nationwide population-based study in Norway. Pediatr Infect Dis J. 2016; 35: 1-6.
17. Schulfer A., Blaser M.J. Risks of antibiotic exposures in life of the developing microbiome. PLoS Pathog. 2015; 11: e1004903.
18. Centres for Disease Control and Prevention (CDC). CDC 12-step program to prevent antimicrobial resistance in health care settings. April 19, 2002. URL: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5115a5.htm date of access January 23, 2017)
19. World Health Organization (WHO). World Health Organization Global Strategy for Containment of Antimicrobial Resistance. 2001. URL: https://www.who.int/drugresistance/WHO_Global_Strategy.htm/en/ (date of access January 23, 2017)
20. Cantey J.B., Patel S.J. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014; 28: 247-61.
21. Patel S.J., Rosen E., Zaoutis T., et al. Neonatologists’ perceptions of antimicrobial resistance and stewardship in neonatal intensive care unit. Infect Control Hosp Epidemiol. 2010; 31: 1298-300.
22. Holmes A.H. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016; 387: 176-87.
23. De Santis V., Gresiou M., Corona A., et al. Bacteraemia incidence, causative organisms and resistance patterns, antibiotic strategies and outcomes in a single university hospital ICU: continuing improvement between 2000 and 2013. J Antimicrob Chemother. 2015; 70: 273-8.
24. Ruppe E., Woerther P.L., Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015; 5: 61.
25. Rhodes A., Evans L.E., Alhazzani W., et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43: 304-77.
26. De Jong E., Van Oers J.A., Beishuizen A., et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomized, controlled, open-label trial. Lancet Infect Dis. 2016; 16: 819-27.
27. Baer G., Baumann P., Buettcher M., et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One. 2013; 8: e68419.
28. Deftos L.J., Roos B.A., Parthemore J.G. Calcium and skeletal metabolism. West J Med. 1975; 123 (6): 447-58.
29. Gel’fand B.R., Burnevich S.Z., Gel’fand E.B., Brazhnik T.B., et al. Biochemical markers of a systemic inflammatory response: the role of procalcitonin in the diagnosis of sepsis. Infektsii v khirurgii [Infections in Surgery]. 2007; 5 (1): 17-24. (in Russian)
30. Vel’kov V.V. Procalcitonin and C-reactive protein in modern laboratory diagnostics. Kliniko-laboratorniy konsilium [Clinical Laboratory Consultation]. 2009; 1 (26): 34-48. (in Russian)
31. Becker K.L., Snider R., Nylen E.S. Procalcitonin assay in systemic inflammation, infection and sepsis: clinical utility and limitation. Crit Care Med. 2008; 36 (3): 941-95.
32. Vouloumanou E.K., Plessa E., et al. Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med. 2011; 37: 747 -62.
33. Van Rossum A.M., Wulkan R.W., et al. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004; 4: 620-30.
34. Chiesa C., Panero A., Rossi N., et al. Reliability of procalcitonin concentration for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998; 26: 664-72.
35. Trippella G., Galli L., De Martino M., Lisi C., et al. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2017; 15 (11): 1041-57.
36. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Crit Care Med. 2010; 38 (11): 2229-41.
37. Assumma M., Signore F., Rossi N., et al. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem. 2003; 49: 60-8.
38. Chiesa C., Pelegrini G., Panero A., et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications and infection. Clin Chem. 2003; 49: 60-8.
39. Lee J., Bang Y.H., Lee E.H., et al. The influencing factors on procalcitonin values in newborns with noninfectious conditions during the fist week of life. Korean J Pediatr. 2017; 60 (1): 10-6.
40. Kordek A., Torbe A., Tousty J., et al. The determination of procalcitonin concentration in early-onset neonatal infection. Clin Pediatr (Phila). 2017; 56 (4): 333-40.
41. Stocker M., Fontana M., El Helou S., et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010; 97: 165-74.
42. Stocker M., Herk W., El Helou S., et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomized controlled trial (NeoPIns). Lancet. 2017; 390: 871-81.
43. Vinclair C., Timsit J.F., Bouadma L. The NeoPIns study: a step towards a rational use of antibiotics in early-onset sepsis in term neonates. J Emerg Crit Care Med. 2017; 1: 45.
44. Merker M., Bolliger R., Schuetz P. Procalcitonin-guided decision making results in a significant reduction of antibiotic therapy and hospital stay in neonates with suspected early-onset sepsis. BMJ Evidence-Based Medicin e On line. First pu blished on March 9, 2018.
URL: https://pubmed.ncbi.nlm.nih.gov/30054447-procalcitonin-guided-decision-making-results-in-a-significant-reduction-of-antibiotic-therapy-and-hospital-stay-in-neonates-with-suspected-early-onset-sepsis/
doi: 10.1136/bmjebm-2017-110838
45. Aravena M. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis. Rev Chilena Infectol. 2017; 34 (5): 522.
46. Mathur N.B., Behera B. Blood procalcitonin levels and duration of antibiotics in neonatal sepsis. J Trop Pediatr. 2018; Aug 24: 1-6.